148 related articles for article (PubMed ID: 12118430)
1. Baseline levels of plasma endothelin-1 (ET-1) and changes during transfusion in thalassemic patients.
Viprakasit V; Kankirawatana S; Akarasereenont P; Durongpisitkul K; Chotewuttakorn S; Tanphaichitr VS
Am J Hematol; 2002 Jul; 70(3):260-2. PubMed ID: 12118430
[TBL] [Abstract][Full Text] [Related]
2. Hemorheological changes in blood transfusion-treated beta thalassemia major patients.
Mangalani M; Lokeshwar MR; Banerjee R; Nageswari K; Puniyani RR
Clin Hemorheol Microcirc; 1998 Jul; 18(2-3):99-102. PubMed ID: 9699030
[TBL] [Abstract][Full Text] [Related]
3. High transfusion in children with beta-thalassemia/Hb E: clinical and laboratory assessment of 18 cases.
Torcharus K; Withayathawornwong W; Sriphaisal T; Krutvacho T; Arnutti P; Suwanasophorn C
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():96-9. PubMed ID: 7886617
[TBL] [Abstract][Full Text] [Related]
4. Difference in pattern of erythropoietin response between beta-thalassemia/hemoglobin E children and adults.
Sukpanichnant S; Opartkiattikul N; Fucharoen S; Tanphaichitr VS; Hasuike T; Tatsumi N
Southeast Asian J Trop Med Public Health; 1997; 28 Suppl 3():134-7. PubMed ID: 9640615
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of oxidative stress-induced changes in thalassemic erythrocytes by vitamin E.
Das N; Das Chowdhury T; Chattopadhyay A; Datta AG
Pol J Pharmacol; 2004; 56(1):85-96. PubMed ID: 15047982
[TBL] [Abstract][Full Text] [Related]
6. Serum erythropoietin levels in pediatric patients with beta-thalassemia/hemoglobin E.
Paritpokee N; Wiwanitkit V; Bhokaisawan N; Boonchalermvichian C; Preechakas P
Clin Lab; 2002; 48(11-12):631-4. PubMed ID: 12465748
[TBL] [Abstract][Full Text] [Related]
7. Serum erythropoietin levels in thalassemia major and intermedia.
Chaisiripoomkere W; Jootar S; Chanjarunee S; Ungkanont A
Southeast Asian J Trop Med Public Health; 1999 Dec; 30(4):786-8. PubMed ID: 10928378
[TBL] [Abstract][Full Text] [Related]
8. Endothelial dysfunction and inflammatory process in transfusion-dependent patients with beta-thalassemia major.
Aggeli C; Antoniades C; Cosma C; Chrysohoou C; Tousoulis D; Ladis V; Karageorga M; Pitsavos C; Stefanadis C
Int J Cardiol; 2005 Oct; 105(1):80-4. PubMed ID: 16207549
[TBL] [Abstract][Full Text] [Related]
9. Hemostatic alterations in splenectomized and non-splenectomized patients with beta-thalassemia/hemoglobin E disease.
Tripatara A; Jetsrisuparb A; Teeratakulpisarn J; Kuaha K
Thromb Res; 2007; 120(6):805-10. PubMed ID: 17382994
[TBL] [Abstract][Full Text] [Related]
10. Vasoactive factors in sickle cell disease: in vitro evidence for endothelin-1-mediated vasoconstriction.
Ergul S; Brunson CY; Hutchinson J; Tawfik A; Kutlar A; Webb RC; Ergul A
Am J Hematol; 2004 Jul; 76(3):245-51. PubMed ID: 15224360
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of lipids and lipoproteins in Syrian patients with beta-thalassemia major.
Al-Quobaili FA; Abou Asali IE
Saudi Med J; 2004 Jul; 25(7):871-5. PubMed ID: 15235691
[TBL] [Abstract][Full Text] [Related]
12. Hemoglobin E-beta-thalassemia: Progress report from the International Study Group.
Premawardhena A; De Silver S; Arambepola M; Olivieri NF; Vichinsky EP; Merson L; Muraco G; Allen A; Fisher C; Peto T; Weatherall DJ
Ann N Y Acad Sci; 2005; 1054():33-9. PubMed ID: 16339649
[TBL] [Abstract][Full Text] [Related]
13. Decreased transfusion needs associated with hydroxyurea therapy in Algerian patients with thalassemia major or intermedia.
Bradai M; Pissard S; Abad MT; Dechartres A; Ribeil JA; Landais P; de Montalembert M
Transfusion; 2007 Oct; 47(10):1830-6. PubMed ID: 17880608
[TBL] [Abstract][Full Text] [Related]
14. Plasma chitotriosidase activity in patients with beta-thalassemia.
Altarescu G; Rudensky B; Abrahamov A; Goldfarb A; Rund D; Zimran A; Elstein D
Am J Hematol; 2002 Sep; 71(1):7-10. PubMed ID: 12221666
[TBL] [Abstract][Full Text] [Related]
15. Decreased plasma endothelin-1 levels in children with sickle cell disease treated with hydroxyurea.
Lapouméroulie C; Benkerrou M; Odièvre MH; Ducrocq R; Brun M; Elion J
Haematologica; 2005 Mar; 90(3):401-3. PubMed ID: 15749673
[TBL] [Abstract][Full Text] [Related]
16. Plasma adrenomedullin and endothelin-1 concentration during low-dose dobutamine infusion: Relationship between pulmonary uptake and pulmonary vascular pressure/flow characteristics.
Vizza CD; Letizia C; Badagliacca R; Sciomer S; Poscia R; Della Rocca G; Iacoboni C; Leonardo de L; Quattrucci S; Dario C; Luigi P; Fedele F
Regul Pept; 2006 Sep; 136(1-3):85-91. PubMed ID: 16815566
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and clinical effects of vitamin E administration in homozygous beta-thalassemia.
Giardini O; Cantani A; Donfrancesco A; Martino F; Mannarino O; D'Eufemia P; Miano C; Ruberto U; Lubrano R
Acta Vitaminol Enzymol; 1985; 7(1-2):55-60. PubMed ID: 4036760
[TBL] [Abstract][Full Text] [Related]
18. Children with hemoglobin E/β-thalassemia have a high risk of being vitamin D deficient even if they get abundant sun exposure: a study from Thailand.
Nakavachara P; Viprakasit V
Pediatr Blood Cancer; 2013 Oct; 60(10):1683-8. PubMed ID: 23733667
[TBL] [Abstract][Full Text] [Related]
19. Increased circulating big endothelin-1, endothelin-1 and atrial natriuretic peptide in infants and children with heart failure secondary to congenital heart disease.
Yeh JL; Hsu JH; Dai ZK; Liou SF; Chen IJ; Wu JR
Int J Cardiol; 2005 Sep; 104(1):15-20. PubMed ID: 16055212
[TBL] [Abstract][Full Text] [Related]
20. Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.
Italia K; Jain D; Gattani S; Jijina F; Nadkarni A; Sawant P; Nair S; Mohanty D; Ghosh K; Colah R
Blood Cells Mol Dis; 2009; 42(1):25-31. PubMed ID: 18954999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
